PATENT CLAIM ANALYSIS

Application Number: 16289370
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "184100"]

Abstract:
The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.

Claim (Index 22):
The pharmaceutical composition of  claim 13 , wherein:\n (a) the peanut flour comprises 9 mg to 11 mg peanut protein; (b) the one or more diluents comprise (i) pregelatinized starch in an amount from 5% w/w to 20% w/w of the composition , and (ii) microcrystalline cellulose in an amount from 60% w/w to 90% w/w of the composition ; (c) the one or more glidants comprise colloidal silicon dioxide in an amount from 0.01% w/w to 1.0% w/w of the composition; and (d) the one or more lubricants comprise magnesium stearate in an amount from 0.01% w/w to 1.0% w/w of the composition.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 99.0
- Lexical Diversity: 1.63636
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14207127', '15276440', '16111102', '15792716', '14207165']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8254298934837084
- 35 USC 102 Novelty (BERT): 0.6364584708903939
- Combined Prediction Score: 0.8065327512243771
- Mean Citation Score: 592.5243059999998
- Max Citation Score: 698.54193
- Similarity Product: 542.4247942241835

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test